Skip to content
Bored Studies
RecruitingPhase 3

Study to Assess KN3835 in the Treatment of Flexible/Semi-Flexible Hammertoe (HMT)

Endo USA Inc., a Keenova Therapeutics Company · NCT07759362

View Study & Apply (opens in a new tab)

Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.

Key facts

Compensation
Not posted. Ask the study team before screening.
Who can join
Ages 18–75 · All sexes
Healthy volunteers
Not accepted (a condition is required)
Study type
Interventional · Phase 3
Target enrollment
554
US sites recruiting
7
Study start
August 11, 2026
Record last updated
September 14, 2026

Status re-checked against ClinicalTrials.gov within the last 12 hours.

What the study is about

The primary purpose of this study is to assess the efficacy, safety, and tolerability of KN3835 compared to placebo in the treatment of flexible/semi-flexible HMT.

Being studied: KN3835; Placebo

Conditions: Flexible Hammertoe; Semi-flexible Hammertoe

Eligibility criteria

Copied from the official record. The study team makes the final decision at screening.

Show full criteria

Key Inclusion Criteria

  • Has no significant medical history or examination findings related to the foot to be treated, which in the investigator's opinion, would make the participant unsuitable for study intervention administration or study required evaluations.
  • If female, be of non-childbearing potential or, if of childbearing potential, be non-pregnant, non-lactating and agree to use effective contraception when with a male partner for the duration of the study and for 28 days after treatment.
  • Be willing and able to comply with all protocol required visits and assessments.

Key Exclusion Criteria

  • Has any musculoskeletal, neurosensory, other neurological or related disorder that affects the participant's use of his/her feet and/or would impair his/her completion of study assessments as determined by the investigator either due to the disorder or due to pain.
  • Has any significant medical condition(s), which in the investigator's opinion would make the participant unsuitable for enrollment in the study.
  • Has previously participated in clinical studies of KN3835 for plantar fasciitis, plantar fibromatosis, or HMT.

Note: Other inclusion/exclusion criteria may apply.

Recruiting US locations

Study contacts (from the official record)

  • Clinical Operations · 800-462-3636 · clinicaltrials@endo.com
Study to Assess KN3835 in the Treatment of Flexible/Semi-Flexible… (NCT07759362) | Bored Studies